Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Laboratory for Molecular Medicine, |
RCV000036243 | SCV000059895 | uncertain significance | not specified | 2011-03-08 | criteria provided, single submitter | clinical testing | Variant classified as Uncertain Significance - Favor Pathogenic. The Leu2193Phe variant in MYO7A has not been reported in the literature nor previously identifi ed by our laboratory. This residue is conserved across species and computational analyses (PolyPhen2, SIFT) suggest that the Leu2193Phe variant may impact the p rotein. However, this information is not predictive enough to assume pathogenici ty. It should be noted that this lab has only sequenced the MYO7A in 20 Asian pr obands and no Asian healthy controls. In addition, healthy control information i s unavailable from either public databases or scientific literature, such that t he full spectrum of benign variation has not yet been defined for this populatio n. Future analysis could reveal that the Leu2193Phe variant is common in this po pulation and therefore unlikely to be pathogenic. However, the presence of this variant in combination with another pathogenic variant in this gene, increases t he likelihood that this variant is pathogenic if found to be in trans (on separa te copies of the gene). In summary, the clinical significance of this variant ca nnot be determined with certainty at this time; however, we would lean towards a more likely pathogenic role. |
| Natera, |
RCV001826555 | SCV002088550 | uncertain significance | Usher syndrome type 1B | 2020-03-21 | no assertion criteria provided | clinical testing |